Press Releases Pharming Group N.V.

Equities

PHARM

NL0010391025

Market Closed - Euronext Amsterdam Other stock markets 11:35:00 2024-04-26 am EDT			5-day change	1st Jan Change
0.9 ^EUR	+2.16%		+2.16%	-12.71%

Apr. 22	Pharming Group to Buy Back EUR123 Million of Bonds due 2025	MT
Apr. 18	Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K	Apr. 25	PU
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders 2024 Rare Impact Awards	Apr. 25	AQ
Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K	Apr. 24	PU
Pharming N : Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	Apr. 24	PU
Pharming Group to report first quarter 2024 financial results on May 8	Apr. 24	GL
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	Apr. 24	GL
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025	Apr. 19	GL
Pharming N : Pharming Group announces the placement of €100 million convertible bonds due 2029	Apr. 19	PU
Pharming Group announces the placement of €100 million convertible bonds due 2029	Apr. 18	GL
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025	Apr. 18	GL
Pharming N : Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	Apr. 08	PU
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	Apr. 08	GL
Pharming N : Pharming Group announces the 2024 Annual General Meeting of Shareholders	Apr. 04	PU
Pharming N : Pharming Group announces the filing of its 2023 Annual Report and Form 20-F	Apr. 04	PU
Pharming N : Notice to Convene AGM 2024	Apr. 04	PU
Pharming N : Explanatory Notes AGM 2024	Apr. 04	PU
Pharming N : Letter Works Council re-appointment Board Members AGM 2024	Apr. 04	PU
Pharming N : Letter Works Council Remuneration Policy AGM 2024	Apr. 04	PU
Pharming N : Updated Remuneration Policy Board of Directors AGM 2024	Apr. 04	PU
Pharming Group announces the 2024 Annual General Meeting of Shareholders	Apr. 04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Pharming Group N.V.

Equities

PHARM

NL0010391025

Press Releases

Filters